Medical information Clinical review pending

Gynecological Testing

FISH Prenatal Screening Panel Chromosomes 13 18 21 X Y Test

A prenatal test using FISH technology to screen for common chromosomal abnormalities (Trisomy 13, 18, 21, and sex chromosome variations) in a developing fetus, aiding in early detection and informed decision-making.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: 10 mL (minimum 7 mL) of amniotic fluid collected in a sterile, screw-capped container.
Results: Confirm with the laboratory before booking.
Preparation: Amniocentesis procedure is typically performed between 15 and 20 weeks of gestation. Confirm specific preparation instructions with your healthcare provider. A Prenatal Genetic Testing Consent Form (Form 18) & Chromosome & FISH analysis Requisition Form (Form 17) are required.

Test priceKSh 24,102

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the FISH Prenatal Screening Panel Chromosomes 13 18 21 X Y Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Advanced maternal age (35 years or older)
✓Family history of chromosomal abnormalities
✓Previous pregnancy affected by a chromosomal disorder
✓Abnormal findings on prenatal ultrasound
✓Abnormal results from other prenatal screening tests
✓Parental chromosomal abnormalities

In plain language

What this test helps you understand

This test helps identify potential chromosomal abnormalities in a fetus, providing crucial information for prenatal care, genetic counseling, and informed decision-making regarding the pregnancy and potential interventions.

The FISH Prenatal Screening Panel for Chromosomes 13, 18, 21, X, and Y is a diagnostic test used during pregnancy to detect specific chromosomal abnormalities in the fetus. This test employs Fluorescence In Situ Hybridization (FISH) technology, which allows for the visualization of specific chromosome segments. It focuses on identifying potential issues with chromosomes 13, 18, and 21 (associated with Patau syndrome, Edwards syndrome, and Down syndrome, respectively), as well as the sex chromosomes (X and Y). Early detection of these conditions can provide valuable information for managing the pregnancy and preparing for the baby's needs. This test is particularly relevant for expectant parents who may have increased risk factors.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationAmniocentesis procedure is typically performed between 15 and 20 weeks of gestation. Confirm specific preparation instructions with your healthcare provider. A Prenatal Genetic Testing Consent Form (Form 18) & Chromosome & FISH analysis Requisition Form (Form 17) are required.

Sample10 mL (minimum 7 mL) of amniotic fluid collected in a sterile, screw-capped container.

MethodologyFluorescence In Situ Hybridization (FISH) analysis of amniotic fluid cells.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test screens for specific chromosomal abnormalities (13, 18, 21, X, Y). It does not detect all possible genetic conditions or smaller chromosomal changes. Results need interpretation by a qualified healthcare professional.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

This test specifically looks for abnormalities in chromosomes 13, 18, 21, and the sex chromosomes (X and Y), such as trisomies (an extra copy of a chromosome).

The sample is typically collected via amniocentesis, usually performed between 15 and 20 weeks of gestation.

A sample of amniotic fluid is required for this test.

Results should be interpreted by a qualified healthcare professional, often in consultation with a genetic counselor, to understand their significance.

Yes, this test is considered diagnostic for the specific chromosomal abnormalities it screens for.

A Prenatal Genetic Testing Consent Form (Form 18) & Chromosome & FISH analysis Requisition Form (Form 17) are mandatory.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp